- Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, et al. (2000) Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nature Medicine 6, 1167–1175.
- Copeland C, Curzner ML, Groome N & Diemel LT (2000) Temporal analysis of growth factor mRNA expression in myelinating rat brain aggregate cultures: increments in CNTF, FGF-2, IGF-I, and PDGF-AA mRNA are induced by antibody- mediated demyelination. Glia 30, 342–351.
- De la Pressa Owens S & Innis SM (2000) Diverse, region specific effects of addition of arachidonic and docosahexaenoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters. Pediatr Res 48, 125–130.
- Harbige LS, Layward L, Morris-Downes MM, et al. (2000) The protective effects of omega-6 fatty acids in experimental autoimmune
encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol 122, 445–452.
- Martinez M, Vazquez E, Garcia-Silva MT, et al. (2000) Therapeutic
effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. Am. J. Clin. Nutr 71, Suppl, 376S–85S.
- Nordvik I, Myhr K-M, Nyland H & Bjerve KS (2000) Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta. Neurol Scand 102, 143–149.
- Xiang M, Alfven G, Blennow M, Trygg M & Zetterstrom R (2000) Long chain polyunsaturated fatty acids in human milk and brain growth during early infancy. Acta Paediatr 89, 142–147.
- Zhang SM, Willet WC, Hernan MA, Olek MJ & Ascherio A (2000) Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 152, 1056–1064.
- De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM & Arnold DL (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol. 58, 65–70.
- Lassmann H, Bruck W & Lucchinettii C (2001) Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends in Molecular Medicine. 7, 115–121.
- Tejada-Simon MV, Hong J, Rivera VM, et al. (2001) Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol 31, 907–917.
- Bjartmar C, Wujek JR & Trapp BD (2003) Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neuro. Sci. 206, 165–171.
- Harbige LS (2003) Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38, 323–341.
- Hollifield RD, Harbige LS, Pham-Dinh D & Sharief M (2003) Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission. Autoimmunity 36, 133–141.
- Hafler DA (2004) Multiple Sclerosis. J. Clin Invest. 113, 788–794.
- Matute C & Perez-Cerda F (2005) Multiple sclerosis: novel perspectives on newly forming lesions. Trends in Neurosciences 28, 173–175.
- Van Meeteren ME, Baron W, Beermann C, Dijkstra CD & van Tol EA (2006) Polyunsaturated fatty acid supplementation stimulates differentiation of oligodendroglia cells. Dev Neurosci 28, 196–208.
- Xiang M, Rahman MA, Ai H, Li X & Harbige LS (2006) Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab 50, 492–498.
- Birch EE, Garfield S, Castaneda Y, Hughbanks-Wheaton D, Uauy R & Hoffman D (2007) Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early. Hum. Dev. 83, 279–284.
- Conklin SM, Gianaros PJ, Brown SM, et al. (2007) Long-chain omega-3 fatty acid intake is associated positively with corticolimbic grey matter volume in healthy adults. Neurosci Lett 421, 209–212.
- Harbige, L S and Sharief M (2007) Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis, British Journal of Nutrition , 98, Suppl. 1, S46-S53